Medical Center of the University of Pecs, 1st Clinic for Internal Medicine

Pécs 7624

0 studies enrolling now · 2 studies all time

What they study most

Disease, Hodgkin, Multiple Myeloma

Studies at this site

• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma — Completed